MCRB SERES THERAPEUTICS INC Capital Structure Changes 8-K Filing 2024 - Annual Meeting Approval Seres Therapeutics, Inc. held its 2024 Annual Meeting of Stockholders and approved an amendment to increase the number of authorized shares of Common Stock.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC